Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo

    loading  Checking for direct PDF access through Ovid

Abstract

We studied the effects of a 2-week period of oral raloxifene therapy on the cardiac level of nitric oxide (NO) and on the susceptibility to angina in ovariectomized rats. Ovariectomy decreased the activity of Ca2+-dependent nitric oxide synthase (NOS) in the left ventricle, an effect restored by raloxifene (0.2–5 mg kg−1 day−1) or 17β-oestradiol (0.3 mg kg−1 day−1). Ovariectomy led to a significant ST segment depression after the injection of (1) ornithine-vasopressin (0.5 IU kg−1, i.v.) or (2) epinephrine (10 μg kg−1, i.v.), followed 30 s later by phentolamine (15 mg kg−1, i.v.); both effects were reversed by raloxifene or 17β-oestradiol treatment. Inhibition of nitric oxide synthase (with NG-nitro-l-arginine methyl ester [l-NAME]; 5 mg kg−1, s.c.) augmented the ST segment depression in the ovariectomized rat and abolished the anti-ischaemic effect of 17β-oestradiol or raloxifene. Thus, an oestrogen deficiency down-regulates the cardiac constitutive nitric oxide synthase, which increases the susceptibility of the heart to ishaemia because both actions can be blocked by exogenous administration of the natural oestrogen 17β-oestradiol or the selective oestrogen-receptor modulator (SERM) raloxifene. In the present in vivo system, raloxifene exerts oestrogen-agonist properties.

Related Topics

    loading  Loading Related Articles